Hims & Hers Health is trading 5.33% up at €25.28 after participating in a broad healthcare-sector rally.
- Healthcare stocks benefited from Moderna’s sharp advance following positive late-stage cancer-treatment results.
- Easing Treasury yields improved risk appetite, while the S&P 500 healthcare sector rose more than 3% during the August 19 session.
- No new company-specific catalyst clearly explains the move.